Stock Financial Ratios


BTX / BioTime, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price2.54
Volume208,400.00
Market Cap ($M)279.74
Enterprise Value ($M)0.00
Book Value ($M)117.93
Book Value / Share1.18
Price / Book2.34
NCAV ($M)0.12
NCAV / Share0.00
Price / NCAV2,336.96
Income Statement (mra) ($M)
Revenue5.92
EBITDA-58.97
Net Income18.62
Balance Sheet (mrq) ($M)
Cash & Equivalents0.00
Cash / Share0.00
Assets0.00
Liabilities0.00
Quick Ratio
Current Ratio
Management Effectiveness (mra)
Return on Invested Capital (ROIC)0.16
Return on Assets (ROA)157.81
Return on Equity (ROE)0.16
Identifiers and Descriptors
CUSIP09066L105
Central Index Key (CIK)876343
Industry Groups
SIC 2836 - Biological Products, Except Diagnostic Substances (Biotech)
Other Related CUSIPS
09066L905
09066L955
Share Statistics
Common Shares Outstanding (M)0.00
Scoring Models
Piotroski F Score3.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Per Share Metrics
Inventory Work In Progress Per Share0.00
Property Plant And Equipment Net Per Share0.00
Additional Paid In Capital Per Share0.00
Long Term Debt Per Share0.00
Treasury Stock Per Share0.00
Debt Per Share0.00
Assets Per Share0.00
Deferred Income Tax Liabilities Per Share0.00
Assets Other Non Current Per Share0.00
Liabilities Other Non Current Per Share0.00
Intangibles Per Share0.00
Goodwill Per Share0.00
Accumulated Depreciation And Depletion Per Share0.00
Equity Per Share0.00
Liabilities Current Per Share0.00
Minority Interest Per Share0.00
Current Portion Of Long Term Debt Per Share0.00
Property Plant And Equipment Gross Per Share0.00
Accounts Receivable Per Share0.00
Property Plant And Equipment Per Share0.00
Inventory Raw Materials Per Share0.00
Liabilities Per Share0.00
Cash And Equivalents Per Share0.00
Assets Other Current Per Share0.00
Cash Per Share0.00
Inventory Finished Goods Per Share0.00
Accounts Payable Per Share0.00
Preferred Stock Value Outstanding Per Share0.00
Assets Non Current Per Share0.00
Inventory Per Share0.00
Retained Earnings Per Share0.00
Liabilities And Stock Equity Per Share0.00
Assets Current Per Share0.00

Related News Stories

BioTime's (BTX) CEO Michael West on Q3 2017 Results - Earnings Call Transcript

2017-11-10 seekingalpha
Greetings, and welcome to BioTime, Inc. Third Quarter 2017 Earnings Conference Call. [Operator Instructions]. As a reminder, this conference is being recorded. A replay of the conference call will be available for 7 business days beginning about 2 hours after the conclusion of the live call by calling toll free from U.S. or Canada at 1844-512-2921. International callers, 1412-317-6671. User conference ID number or pin 136-71848. (7-1)

Your Daily Pharma Scoop: AZN's Imfinzi SBLA; Ablynx U.S. IPO; Is Teva A Buy?

2017-10-18 seekingalpha
This abridged "Daily Scoop" is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. (389-1)

BRIEF-Biotime announces first patient in U.S. clinical trial treated for facial volume deficit

2017-10-11 reuters
* Biotime Inc - ‍Biotime expects to file CE Mark application by end of this year with possible approval and launch next year​ (9-1)

3 Things In Biotech You Should Learn Today: October 3, 2017

2017-10-03 seekingalpha
Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research. (42-3)

CUSIP: 09066L105